All Episodes

Talk Liver To Me - Liver Transplantation: Rise of the machines

Talk Liver To Me - Spontaneous Bacterial Peritonitis: Time to Rethink the Rules?

EASL DeepDive: Key Updates in the EASL Clinical Practice Guidelines on extrahepatic Cholangiocarcinoma (eCCA)

Talk Liver To Me - World Liver Day: Making Lifestyle Change Possible

EASL DeepDive: Key Changes in the New EASL HBV Guidelines

EASL DeepDive: EASL Clinical Practice Guidelines on the management of autoimmune hepatitis

EASL DeepDive: The Pursuit of a Cure: HCC Management Strategies

Talk Liver To Me - Baveno VIII: The takeaways you shouldn’t miss

Talk Liver To Me - Updated BCLC Guidelines for HCC: Protocolised or Patient-Centred Care?

Talk Liver To Me - When Cure isn’t the only goal: Palliative Care in Advanced Liver Disease

Talk Liver To Me - MetALD in Practice: Does it Change How We Treat Patients?

Talk Liver To Me - From imposter syndrome to influence: Women shaping hepatology

Talk Liver To Me - Hepatology Ward Rounds: East Meets West

EASL Studio Podcast: Collaborating across disciplines to find the best solution for people living with PBC

EASL Studio Podcast: What Can Be Done to Safeguard Young Adults from SLD?

EASL Studio Podcast: Decoding AASLD The Liver Meeting: Trends Shaping Hepatology

EASL Studio Podcast: Rifaximin for Hepatic Encephalopathy: Balancacing Benefits and Risks in the Era of Antimicrobial Resistance

EASL Studio Podcast: Behind the Decision: How Can You Maximize Your Chances of Publication in JHEP Reports?

EASL Studio Podcast: Are we finally entering an era of effective treatment for PSC?

EASL Studio Podcast: Does it really matter whether we call it ACLF or acute decompensation?

EASL Studio Podcast: The Clinical Blind Spot: Are We Neglecting Alcohol?

EASL Studio Podcast: Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025?

EASL Studio Podcast: What Matters Most? The questions every hepatologist should ask their patients

EASL DeepDive: Diagnosis, non-invasive screening and risk stratification of MASLD cases

EASL Studio Podcast: EASL CPGs on Vascular Liver Diseases: What’s New?

EASL DeepDive: MASLD Cirrhosis: Addressing unmet needs and defining valuable endpoints

EASL Studio Podcast: Steatotic Liver Disease Unpacked: Targeting Dynamic Risks

EASL Studio Podcast: Artificial Intelligence: Is This the Beginning of the End of the Medical Profession as We Know It?

EASL Studio Podcast: Rethinking Hepatitis B: Discussions with Patients – Adapting to Expanding Treatment Guidelines

EASL Studio Podcast: Interprofessional Session: Implementing the New EASL MASLD Guidelines into Clinical Practice

EASL Studio Podcast: Landmark studies at EASL Congress 2025

EASL Studio Podcast: Screening strategies for liver fibrosis

EASL Studio Podcast: Beyond the myths: Alcohol harm and policy action

EASL/CIRSE Studio Podcast: Interventional radiology in hepatology: Building bridges to optimise care

EASL DeepDive: Key for TIPS Success: Identifying Suitable Candidates and Risk Control

EASL Studio Podcast: Endoscopic Management of Variceal Bleeding: Outdated or Evolving Beyond Tradition?

EASL DeepDive: Evolving insights in role and management of Alpha-1 Antitrypsin Deficiency

EASL DeepDive: Understanding and managing PBC symptoms

EASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?

EASL DeepDive: What is the future of PBC treatment?

EASL Studio Podcast: JHEP Live: JHEP at 40: What to Expect Next?

EASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big Questions

EASL Studio Podcast: From Evidence to Action: Reducing Alcohol-Related Harm

EASL Studio Podcast: Understanding Sex Disparities in MASLD

EASL Studio Podcast: Lessons from Your PET: Understanding and Evaluating Treatment for Wilson’s Disease

EASL Studio Podcast: Liver Cancer Care in 2025: Progress, Hope, and What Lies Ahead

EASL Studio Podcast: YI choice: From Idea to Abstract to Publication: Navigating Your Research journey

EASL Studio Podcast: JHEP Live – EASL CPGs on Hepatocellular Carcinoma: What’s New and How Will Practice Change?

EASL Studio Podcast: 2025 Update on Steatotic Liver Disease: Rethinking Standard of Care

EASL Studio Podcast: The liver as a master regulator of ageing, health, and longevity

EASL Studio Podcast: TIPS: How far can we go?

EASL Studio Podcast: Sarcopenia: Converting research findings into clinical practice - Are we doing enough?

EASL Studio Podcast: Alcohol, cardiometabolic risks factors, and steatotic liver disease – From stigma to breakthrough therapies

EASL Studio Podcast: What’s hot and not in liver transplantation: EASL CPG 2024 update

EASL Studio Podcast: Why does WHO engagement with Steatotic Liver Disease matter?

EASL Studio Podcast: Is it time to abandon the use of ultrasound for HCC surveillance in MASLD?

EASL Studio Podcast: Are we relearning how to manage renal dysfunction in cirrhosis?

EASL Studio Podcast: Arrivederci Milano, hallo Amsterdam!

EASL Studio Podcast: Education at the heart of EASL’s mission

EASL Studio Podcast: Landmark studies at the EASL Congress 2024

EASL Studio Podcast: SLD nomenclature: Need for refinement?

EASL Studio Podcast: Exploring new frontiers: The AI liver taskforce initiative

EASL Studio Podcast: Advances in systemic treatments in liver cancer

EASL Studio Podcast: Buongiorno Milano: What not to miss during EASL Congress

EASL Studio Podcast: What‘s hot in viral hepatitis in 2024?

EASL Studio Podcast: Endohepatology: The endoscopic liver gold rush

EASL Studio Podcast: Resmetirom: First approved drug for MASH, for whom and for how long?

EASL Studio Podcast: Do we care enough about the importance of DILI/DHILI ?

EASL Studio Podcast: Assessment of clinically significant portal hypertension in 2024 – Is it time to say goodbye to invasive measurements?

EASL Studio Podcast: YI Choice: Citizen science: Societal engagement in hepatology

EASL Studio Podcast: Therapy hierarchy in HCC: A new kid on the block

EASL Studio Podcast: Is there a role for measuring blood ammonia in patients with cirrhosis?

EASL Studio Podcast: The impact of policy measure in preventing liver diseases: The Hepahealth II study

EASL Studio Podcast: Alpha-1-antitrypsin deficiency (AATD): A poster child for genetic therapy

EASL Studio Podcast: JHEP Live: Should the compensated advanced chronic liver disease (cACLD) concept replace cirrhosis?

EASL Studio Podcast: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyond

EASL Studio Podcast: How to stop recurrent bleeding due to small-intestinal angiodysplasia?

EASL Studio Podcast: Do we solve MASLD by treating obesity?

EASL Studio Podcast: EASL Studio’s holiday reflection: A look back to leap forward

EASL Studio Podcast: Hepatic encephalopathy: Underdiagnosed and underestimated

EASL Studio Podcast: Basics in decision-making for liver cancer treatment

EASL Studio Podcast: PSC and AIH overlap syndrome: does it actually exist?

EASL Studio Podcast: The window hypothesis again, or just a closed window?

EASL Studio Podcast: Why should diabetologists care about the liver?

EASL Studio Podcast: Alcohol and the new nomenclature – A game-changer?

JHEP Live: Hepatitis delta’s latest debate: Updates straight from EASL’s slate

EASL Studio Podcast: Why bother with diet and exercise when an injection will suffice?

EASL Studio Podcast: YI Choice: When stars fade: The untold story of burnout in academia

EASL Studio Podcast: JHEP Live: The new nomenclature for SLD: A multidisciplinary evaluation and approach

EASL Studio Podcast: Highlights from the EASL SLD Summit 2023

EASL Studio Podcast: Zoonotic Hepatitis E – What’s hot in 2023?

EASL Studio Podcast: Are 30% of the global population sick? A critical view on Steatotic Liver Disease and care pathways

EASL Studio Podcast: What is really new in the EASL CPG on ACLF?

EASL Studio Podcast: United we stand: Global societies collaborating to beat liver disease

EASL Studio Podcast: EASL Congress 2023: Back to the future

EASL Studio Podcast: Highlights of liver cancer research at EASL Congress 2023

EASL Studio Podcast: The battle to reduce alcohol harms… EASL’s new policy

EASL Studio Podcast: Steatotic liver disease global consensus to change nomenclature

EASL Studio Podcast: Practice changing highlights from EASL Congress 2023

EASL Studio Podcast: The conundrum of NASH: The growing global disease burden with low disease awareness

EASL Studio Podcast: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio Podcast: Why you should stop smoking if you love your liver

EASL Studio Podcast: COST Actions: Opportunities for pan-European collaborations in liver diseases

EASL Studio Podcast: Promoting Liver Health: An urgent call for action at WHO

EASL Studio Podcast: HDV: The devil becomes treatable

EASL Studio Podcast: Liver nurses in Europe: Are there enough and can they do more?

EASL Studio Podcast: Albumin in cirrhosis: For all, for some, for none

EASL Studio Podcast: Highlights from the EASL Liver Cancer Summit 2023

EASL Studio Podcast: Diagnostic and therapeutic challenges in Wilson’s disease

EASL Studio Podcast: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance

EASL Studio Podcast: EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failure

EASL Studio Podcast: JHEP Live: Liver transplantation for alcohol-related hepatitis

EASL Studio Podcast: NAFLD and NASH – moving beyond the liver biopsy – where are we now?

EASL Studio Podcast: YI Choice: Gene therapy for liver disease — RNA interference and beyond

EASL Studio Podcast: Ascites: New solution for an old problem?

EASL Studio Podcast: YI Choice: Gender equality in academics — reducing the gap

EASL Studio Podcast: Alcohol and food policies

EASL Studio Podcast: Regenerating the liver graft with a machine?

EASL Studio Podcast: AI for Dummies

EASL Studio Podcast: JHEP Live: Is the term ‘decompensated cirrhosis’ outdated?

EASL Studio Podcast: A 360 approach to beat alcohol-related liver disease

EASL Studio Podcast: YI Choice: How to build consortia and registries

EASL Studio Podcast: Hepatitis B elimination: How far behind are we and what do we need to change to achieve it?

EASL Studio Podcast: Liver cancer in 2022: Wrap-up & outlook

EASL Studio Podcast: Chronic portal vein thrombosis: Anticoagulation and interventional radiology for all patients?

EASL Studio Podcast: The future of hepatology

EASL Studio Podcast: Next-generation metrics for science beyond Journal impact factor and citations: The role of social media

EASL Studio Podcast: Meeting the challenge of antimicrobial resistance (AMR) in cirrhosis: the invisible threat that lies within

EASL Studio Podcast: Regenerative Hepatology: From stem cells to tissue engineering

EASL Studio Podcast: JHEP Live: Antisense oligonucleotides vs. siRNAs in the treatment of chronic hepatitis B: Who will be the winner, if at all?

EASL Studio Podcast: Transplanting patients with cancer – Is there a limit?

EASL Studio Podcast: Bugs and the liver — The role of the gut microbiome in liver diseases

EASL Studio Podcast: How to improve end-of-life care in liver disease?

EASL Studio Podcast: JHEP Live: Stigma and alcohol

EASL Studio Podcast: Special Edition: Highlights of EASL NAFLD Summit 2022

EASL Studio Podcast: Liver transplantation for ACLF: Opportunities, challenges and pitfalls

EASL Studio Podcast: JHEP Live: Covid vaccination and associated autoimmune hepatitis

EASL Studio Podcast: Teatime - 25 June 2022

EASL Studio Podcast: Teatime - 24 June 2022

EASL Studio Podcast: Teatime - 23 June 2022

EASL Studio Podcast: Teatime - 22 June 2022

EASL Studio Podcast: Midday Talks on Improving Liver Cancer Care and Prevention - 23 June 2022

EASL Studio Podcast: How can our response to the climate crisis transform and improve hepatology services?

EASL Studio Podcast: EASL Haemochromatosis Guidelines 2022

EASL Studio Podcast: JHEP Live on the best animal model for HCC – Lost in translation?

EASL Studio Podcast : Digital Pathology

EASL Studio Podcast: Nurse and AHP Focus: Sustainable Hepatology – Insights in nursing initiatives

EASL Studio Podcast - YI Choice: Propelling liver cell biology into the third dimension

EASL Studio Podcast: Should anticoagulants be given to patients with cirrhosis to improve outcome?

EASL Studio Podcast: New era for science dissemination: The role of social media

EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?

Liver Cancer